[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @PsychedVantage Psychedelic Vantage Psychedelic Vantage posts on X about $mnmd, $cmps, $cybn, $atai the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::1461655010958315520/interactions)  - X Week XXX +52% - X Month XXXXXX -XX% - X Months XXXXXXX +209% - X Year XXXXXXX +412% ### Mentions: X [#](/creator/twitter::1461655010958315520/posts_active)  - X Month XX -XX% - X Months XXX +195% - X Year XXX +264% ### Followers: XXXXX [#](/creator/twitter::1461655010958315520/followers)  - X Week XXXXX +1.20% - X Month XXXXX +4.70% - X Months XXXXX +38% - X Year XXXXX +88% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::1461655010958315520/influencer_rank)  ### Social Influence **Social category influence** [stocks](/list/stocks) [finance](/list/finance) **Social topic influence** [$mnmd](/topic/$mnmd) #1, [$cmps](/topic/$cmps) #1, [$cybn](/topic/$cybn) #1, [$atai](/topic/$atai) #1, [$ghrs](/topic/$ghrs) #1, [$xbi](/topic/$xbi), [$bbc](/topic/$bbc), [bbc](/topic/bbc), [$axsm](/topic/$axsm), [compound](/topic/compound) **Top accounts mentioned or mentioned by** [@atailife](/creator/undefined) [@cangermayer](/creator/undefined) [@cybininc](/creator/undefined) [@psychedalpha](/creator/undefined) [@brandonjob23](/creator/undefined) [@beckleypsytech](/creator/undefined) [@waracken](/creator/undefined) [@smallpharma](/creator/undefined) [@mindsetpharma](/creator/undefined) [@insidepharma](/creator/undefined) [@gilgameshrx](/creator/undefined) [@culperresearch](/creator/undefined) [@elonmusk](/creator/undefined) [@zetaboy69](/creator/undefined) [@investingincan1](/creator/undefined) [@c2412345](/creator/undefined) [@advisorshares](/creator/undefined) [@mindmedco](/creator/undefined) [@compasspathway](/creator/undefined) [@cybinincs](/creator/undefined) **Top assets mentioned** [ATAI Life Sciences (ATAI)](/topic/$atai) [Bitcoin Incognito (XBI)](/topic/$xbi) [Axsome Therapeutics, Inc (AXSM)](/topic/$axsm) [AbbVie Inc (ABBV)](/topic/$abbv) ### Top Social Posts Top posts by engagements in the last XX hours "8th Annual Evercore Healthcare Conference Coral Gables FL $MNMD Dec X 2025 12:30 pm EST Link:" [X Link](https://x.com/PsychedVantage/status/1995868492021858332) 2025-12-02T14:51Z 1662 followers, XXX engagements "Long post 🚨 $CMPS $MNMD $CYBN $ATAI $GHRS Yes this is a small dataset but we are consistently seeing better outcomes across studies evaluating psychedelics as adjunctive treatments. Whether this reflects a true synergistic effect or simply that patients are in a better psychological or physiological state when they are not required to withdraw from background medications they have been taking for years is not clear yet. It could be both. Janssen originally evaluated Spravato as an adjunctive therapy in patients who were starting a new oral antidepressant. In a monotherapy study they" [X Link](https://x.com/PsychedVantage/status/1997166696142934049) 2025-12-06T04:50Z 1662 followers, 1516 engagements "$CMPS $MNMD $CYBN" [X Link](https://x.com/PsychedVantage/status/1996077157790183651) 2025-12-03T04:40Z 1661 followers, 1288 engagements "@TheBiotechBear @CulperResearch Didnt these folks short $AXSM" [X Link](https://x.com/PsychedVantage/status/1996726026219426191) 2025-12-04T23:39Z 1662 followers, 1519 engagements "@Zetaboy69 With psilocybin it seems increasingly clear that washout may not be necessary. Im curious whether the same would hold for 5-MeO-DMT in larger studies or if the risk profile differs" [X Link](https://x.com/PsychedVantage/status/1997323809423020418) 2025-12-06T15:14Z 1661 followers, XX engagements "2025 has been quite the year for the psychedelic drug development sector: $CMPS $MNMD $CYBN $ATAI $GHRS We have seen positive mid-late stage data coming from multiple companies across a variety of compounds targeting multiple indications. Nearly $XXX million has been raised in follow-on offerings in the past several months and of course big pharma has acquired a compound in the space (and may I add one that doesn't skip the trip) So what do we have to look forward to in 2026 This post will focus on clinical trial readouts: $CMPS to disclose 9-week data (Part A) from COMP006 together with" [X Link](https://x.com/PsychedVantage/status/1997387574600458677) 2025-12-06T19:28Z 1662 followers, 1537 engagements "Big X publicly trade companies are $CMPS $MNMD $CYBN $ATAI and $GHRS. You can make an argument that $DRUG is a psychedelic stock with their earlier stage programs. You also have Solvonis Therapeutics Tryptamine Therapeutics (I think they changed their name again to something else) BetterLife Pharma Clearmind Medicine and Enveric Biosciences. Outside of $CMPS $MNMD $CYBN $ATAI $GHRS and $DRUG the rest are nano caps. I am personally most bullish on $ATAI and $CYBN as I hold shares in both. But if you asked me which companies I am most bullish on in short term medium term and longterm I would" [X Link](https://x.com/PsychedVantage/status/1997467197376004388) 2025-12-07T00:44Z 1662 followers, XXX engagements "Am I imagining this or has no one publicly complained about AbbVie acquiring Bretisilocin It feels like this acquisition challenges the whole pharma wants to keep people sick narrative. Curious what others think. $CMPS $MNMD $CYBN $ATAI $GHRS" [X Link](https://x.com/PsychedVantage/status/1989793984185581658) 2025-11-15T20:33Z 1662 followers, 1531 engagements "Psychedelic Biotech in 2025: What's Next @flobrand and @LarsWilde $ATAI $CMPS $MNMD $CYBN $GHRS" [X Link](https://x.com/PsychedVantage/status/1998437829311877601) 2025-12-09T17:01Z 1662 followers, 6150 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@PsychedVantage Psychedelic VantagePsychedelic Vantage posts on X about $mnmd, $cmps, $cybn, $atai the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Social category influence stocks finance
Social topic influence $mnmd #1, $cmps #1, $cybn #1, $atai #1, $ghrs #1, $xbi, $bbc, bbc, $axsm, compound
Top accounts mentioned or mentioned by @atailife @cangermayer @cybininc @psychedalpha @brandonjob23 @beckleypsytech @waracken @smallpharma @mindsetpharma @insidepharma @gilgameshrx @culperresearch @elonmusk @zetaboy69 @investingincan1 @c2412345 @advisorshares @mindmedco @compasspathway @cybinincs
Top assets mentioned ATAI Life Sciences (ATAI) Bitcoin Incognito (XBI) Axsome Therapeutics, Inc (AXSM) AbbVie Inc (ABBV)
Top posts by engagements in the last XX hours
"8th Annual Evercore Healthcare Conference Coral Gables FL $MNMD Dec X 2025 12:30 pm EST Link:"
X Link 2025-12-02T14:51Z 1662 followers, XXX engagements
"Long post 🚨 $CMPS $MNMD $CYBN $ATAI $GHRS Yes this is a small dataset but we are consistently seeing better outcomes across studies evaluating psychedelics as adjunctive treatments. Whether this reflects a true synergistic effect or simply that patients are in a better psychological or physiological state when they are not required to withdraw from background medications they have been taking for years is not clear yet. It could be both. Janssen originally evaluated Spravato as an adjunctive therapy in patients who were starting a new oral antidepressant. In a monotherapy study they"
X Link 2025-12-06T04:50Z 1662 followers, 1516 engagements
"$CMPS $MNMD $CYBN"
X Link 2025-12-03T04:40Z 1661 followers, 1288 engagements
"@TheBiotechBear @CulperResearch Didnt these folks short $AXSM"
X Link 2025-12-04T23:39Z 1662 followers, 1519 engagements
"@Zetaboy69 With psilocybin it seems increasingly clear that washout may not be necessary. Im curious whether the same would hold for 5-MeO-DMT in larger studies or if the risk profile differs"
X Link 2025-12-06T15:14Z 1661 followers, XX engagements
"2025 has been quite the year for the psychedelic drug development sector: $CMPS $MNMD $CYBN $ATAI $GHRS We have seen positive mid-late stage data coming from multiple companies across a variety of compounds targeting multiple indications. Nearly $XXX million has been raised in follow-on offerings in the past several months and of course big pharma has acquired a compound in the space (and may I add one that doesn't skip the trip) So what do we have to look forward to in 2026 This post will focus on clinical trial readouts: $CMPS to disclose 9-week data (Part A) from COMP006 together with"
X Link 2025-12-06T19:28Z 1662 followers, 1537 engagements
"Big X publicly trade companies are $CMPS $MNMD $CYBN $ATAI and $GHRS. You can make an argument that $DRUG is a psychedelic stock with their earlier stage programs. You also have Solvonis Therapeutics Tryptamine Therapeutics (I think they changed their name again to something else) BetterLife Pharma Clearmind Medicine and Enveric Biosciences. Outside of $CMPS $MNMD $CYBN $ATAI $GHRS and $DRUG the rest are nano caps. I am personally most bullish on $ATAI and $CYBN as I hold shares in both. But if you asked me which companies I am most bullish on in short term medium term and longterm I would"
X Link 2025-12-07T00:44Z 1662 followers, XXX engagements
"Am I imagining this or has no one publicly complained about AbbVie acquiring Bretisilocin It feels like this acquisition challenges the whole pharma wants to keep people sick narrative. Curious what others think. $CMPS $MNMD $CYBN $ATAI $GHRS"
X Link 2025-11-15T20:33Z 1662 followers, 1531 engagements
"Psychedelic Biotech in 2025: What's Next @flobrand and @LarsWilde $ATAI $CMPS $MNMD $CYBN $GHRS"
X Link 2025-12-09T17:01Z 1662 followers, 6150 engagements
/creator/twitter::PsychedVantage